IRIS
BARILLARI, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 26.463
EU - Europa 1.842
AS - Asia 1.030
SA - Sud America 8
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 2
Totale 29.355
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 26.453
SG - Singapore 631
DE - Germania 421
UA - Ucraina 391
CN - Cina 286
IE - Irlanda 285
IT - Italia 212
RU - Federazione Russa 138
FR - Francia 91
GB - Regno Unito 89
PL - Polonia 89
SE - Svezia 40
FI - Finlandia 33
KR - Corea 33
ID - Indonesia 23
TW - Taiwan 19
JP - Giappone 14
BE - Belgio 12
NL - Olanda 10
CA - Canada 9
ES - Italia 9
HK - Hong Kong 7
PH - Filippine 6
BR - Brasile 5
CZ - Repubblica Ceca 5
AL - Albania 4
DK - Danimarca 4
EU - Europa 3
IN - India 3
ZA - Sudafrica 3
AT - Austria 2
AU - Australia 2
BD - Bangladesh 2
EG - Egitto 2
GR - Grecia 2
LV - Lettonia 2
TR - Turchia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AM - Armenia 1
AR - Argentina 1
BO - Bolivia 1
CH - Svizzera 1
FK - Isole Falkland (Malvinas) 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
LK - Sri Lanka 1
LU - Lussemburgo 1
MA - Marocco 1
RO - Romania 1
Totale 29.355
Salva come PNG Salva come JPEG
Città #
Wilmington 7.693
Woodbridge 7.441
Houston 6.803
Fairfield 619
Chandler 577
Singapore 571
Ann Arbor 391
Dearborn 318
Ashburn 278
Dublin 265
Seattle 224
Cambridge 210
Jacksonville 207
Medford 199
New York 153
Santa Clara 130
Beijing 106
Lawrence 93
Kraków 88
Rome 79
Menlo Park 70
Zhengzhou 67
San Diego 50
Boardman 26
Jakarta 21
Milan 21
Mülheim 19
Redwood City 17
Nanjing 16
Norwalk 15
Verona 13
Brussels 12
Moscow 12
Mountain View 12
Phoenix 10
Shanghai 10
Center 9
Council Bluffs 9
Guangzhou 9
Nuremberg 9
Kaohsiung 8
London 8
Frankfurt am Main 7
Los Angeles 7
University Park 7
Frankfurt Am Main 6
Hefei 6
Helsinki 6
Manila 6
Mcallen 6
San Francisco 6
San Mateo 6
Toronto 6
Wuhan 6
Ayn 5
Kunming 5
Redmond 5
Colorado Springs 4
Engelhard 4
Foggia 4
Halle 4
Indiana 4
Kissimmee 4
Palo Alto 4
Salt Lake City 4
Seoul 4
Baotou 3
Cedarhurst 3
Hounslow 3
Iconha 3
Lappeenranta 3
Magenta 3
Olomouc 3
Osaka 3
Prescot 3
Sacramento 3
Shenyang 3
Shenzhen 3
Tirana 3
Washington 3
Amsterdam 2
Arona 2
Beachwood 2
Cairo 2
Cesano Maderno 2
Chengdu 2
Columbus 2
Durban 2
Farmington 2
Fuzhou 2
Gaeta 2
Guilford 2
Hebei 2
Hong Kong 2
Jiaxing 2
Jinan 2
Kelowna 2
La Veta 2
Las Rozas de Madrid 2
Leipzig 2
Totale 27.096
Salva come PNG Salva come JPEG
Nome #
Detection of high nerve growth factor serum levels in AIDS-related and -unrelated Kaposi's sarcoma patients 482
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 455
HTLV-V: a new human retrovirus isolated in a Tac-negative T cell lymphoma/leukemia 449
Ritonavir or saquinavir impairs the invasion of cervical intraepithelial neoplasia cells via a reduction of MMP expression and activity. 433
The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis 425
HIV-1 Tat regulates endothelial cell cycle progression via activation of the Ras/ERK MAPK signaling pathway 415
Human T-lymphotropic retrovirus infection in Italy 414
Fibroblast growth factor-2 and the HIV-1 Tat protein synergize in promoting Bcl-2 expression and preventing endothelial cell apoptosis: implications for the pathogenesis of AIDS-associated Kaposi’s sarcoma. 410
The HIV protease inhibitor indinavir down-regulates the expression of the pro-angiogenic MT1-MMP by human endothelial cells 408
The fibroblast growth factors. 400
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis 399
Pharmacological management of Kaposi’s sarcoma. 397
Inhibition of MMP-9 expression by ritonavir or saquinavir is associated with inactivation of the AKT/Fra-1 pathway in cervical intraepithelial neoplasia cells 397
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles 396
Inflammatory cytokines stimulate vascular smooth muscle cells locomotion and growth by enhancing alpha5beta1 integrin expression and function 394
Spindle cells from Acquired Immune Deficiency Syndrome-associated Kaposi’s sarcoma lesions express telomerase activity directly relating to the RNA levels of fibroblast growth factor-2. 390
Native HIV-1 Tat protein targets monocyte-derived dendritic cells and enhances their maturation, function, and antigen-specific T cell responses 389
Antitumor effects of antiretroviral therapy 379
HIV-1 Tat addresses dendritic cells to induce a predominant Th1-type adaptive immune response that appears prevalent in the asymptomatic stage of infection 377
Entrance of the tat protein of HIV-1 into human uterine cervical carcinoma cells causes upregulation of HPV-E6 expression and a decrease in p53 protein levels 375
A tricistronic retroviral vector expressing natural antiangiogenic factors inhibits angiogenesis in vitro, but is not able to block tumor progression in vivo 367
Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis. 367
HIV protease inhibitors as new treatment options for Kaposi's sarcoma 365
Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS 365
Follow-up study of patients with cervical intraepithelial neoplasia grade 1 overexpressing p16ink4a. 364
Treatment of Kaposi's sarcoma--an update 362
HTLV-I and HIV infection in drug addicts in Italy 359
Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma 359
Angiogenic properties of human immunodeficiency virus type 1 Tat protein 358
Pathogenesis of AIDS-associated Kaposi's sarcoma 356
Human immunodeficiency virus protease inhibitors reduce the growth of human tumors via proteasome-independent block of angiogenesis and matrix metalloproteinases. 355
Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients 354
Another mechanism involved in AIDS-KS progression. 349
Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth 348
null 345
Transcription of placenta growth factor type-2 correlates with intratumoral microvessel density in breast carcinomas. 341
Release, uptake, and effects of extracellular human immunodeficiency virus type 1 Tat protein on cell growth and viral transactivation 336
The Tat protein of human immunodeficiency virus type 1, a growth factor for AIDS Kaposi sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the RGD amino acid sequence 336
HTLV-I is endemic in southern Italy: detection of the first infectious cluster in a white population 335
The helical domain of GBP-1 mediates the inhibition of endothelial cell proliferation by inflammatory cytokines 333
Human T-lymphotropic retroviruses: a new member of the family. 331
HIV protease inhibitors block angiogenesis and promote regression of Kaposi’s sarcoma in the nude mouse model. 330
Clinical course of classic Kaposi's sarcoma in HIV-negative patients treated with the HIV protease inhibitor indinavir 329
Tat, the transactivator gene of HIV-1, activates the expression of tumor necrosis factor-beta. 324
Spindle cells from AIDS-associated Kaposi's sarcoma (KS) lesions express telomerase activity that is enhanced by KS progression factors. 323
The use of HAART for biological tumour therapy 316
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects (TAT domains and pathways for cell growth and transactivation activity). 314
Immobilized HIV-1 Tat protein promotes gene transfer via a transactivation independent mechanism which requires binding of Tat to viral particles. 313
Release and angiogenic properties of extracellular HIV-1 Tat protein. 313
Activation of matrix-metalloproteinase-2 and membrane-type-1-matrix-metalloproteinase in endothelial cells and induction of vascular permeability in vivo by human immunodeficiency virus-1 Tat protein and basic fibroblast growth factor 311
Immune activation, rather than immune deficiency, cooperates with HIV infection in the development of AIDS-associated Kaposi’s sarcoma. 310
Cytokines and growth factors in the pathogenesis of AIDS-associated Kaposi's sarcoma 309
Basic fibroblast growth factor mediates the growth and angiogenic activity of AIDS-Kaposi’s sarcoma (KS)-derived spindle cells and synergises with HIV-1 Tat protein in inducing KS-like lesions in mice. 309
Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma 303
IFN-gamma induces endothelial cells to proliferate and to invade the extracellular matrix in response to the HIV-1 Tat protein: implications for AIDS-Kaposi's sarcoma pathogenesis 303
Basic fibroblast growth factor modifies the interactions between endothelial cells/fibronectin: Implications for progression of AIDS- associated Kaposi's sarcoma 299
Lymphokines released by activated or HTLV-infected T cells induce growth of normal mesenchymal cells and of cells derived from Kaposi’s sarcoma lesions of AIDS patients. 299
HIV-1 Tat protein mimics the effect of extracellular matrix (ECM) protein on vascular cell growth and angiogenesis: implications for AIDS-Kaposi’s sarcoma (AIDS-KS) pathogenesis. 296
Interactions between endothelial cells and HIV-1 295
Tissue CEA as prognostic indicator in a series of 31 cases of gastric cancer 295
Role of HIV-1 TAT gene product and of cytokines released by activated immune cells in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 294
The formation of new blood vessels in Kaposi’s sarcoma. 293
Biological properties of Human Immunodeficiency Virus type-1 Tat protein: angiogenic effects and adhesive interactions of extracellular Tat. 293
Integrin-mediated uptake of HIV-1 Tat protein by cytokine-activated endothelial cells. 289
Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin 289
PDGF-B as a possible growth factor in AIDS-KS. 288
HIV protease inhibitors are potent anti-angiogenic molecules and promote regression of Kaposi sarcoma 286
HIV protease inhibitors: antiretroviral agents with anti-inflammatory, anti-angiogenic and anti-tumour activity 285
Mechanism of paclitaxel activity in Kaposi's sarcoma 285
Biology of Kaposi's sarcoma 281
Effects of the human immunodeficiency virus type 1 Tat protein on the expression of inflammatory cytokines 281
Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis 280
[Chronic T-lymphocyte lymphatic leukemia. Clinico-pathologic assessment and new epidemiologic data related to cases correlated with HTLV-I in Italy] 280
Multicistronic antiangiogenic retroviral vectors for the gene therapy of malignant brain tumors. 276
The angiogenic properties of HIV-I Tat protein are mediated by two different domains. 270
Release-uptake of HIV-1 Tat and mechanisms of Tat-induced paracrine biological effects. 269
T-helper phenotype chronic lymphocytic leukaemia and "adult T-cell leukaemia" in Italy. Endemic HTLV-I-related T-cell leukaemias in southern Europe 268
Role of cytokines from activated T cells and HIV-1 Tat protein in the pathogenesis of AIDS-associated Kaposi’s sarcoma. 268
Cytokines released by activated primary T cells stimulate the growth of AIDS-KS-derived cells and other cells of mesenchymal derivation. 266
Basic FGF induces lesions in mice resembling KS, and antisense oligonucleotides against this cytokine inhibit the growth and angiogenic activity of KS spindle cells. 264
HIV-1 Tat protein enhances angiogenesis and Kaposi’s sarcoma development triggered by inflammatory cytokines or bFGF by engaging the avb3 integrin. 261
The Tat protein of human immunodeficiency virus type-1 promotes vascular cell growth and locomotion by engaging the alpha5beta1 and alphavbeta3 integrins and by mobilizing sequestered basic fibroblast growth factor 255
Immune stimulation and HIV-1 infection have complementary effects in the induction and progression of AIDS-associated Kaposi’s sarcoma via release of cytokines and Tat. 253
Cooperation of HIV-1 Tat protein, inflammatory cytokines or bFGF in the pathogenesis of AIDS-Kaposis’s sarcoma. 250
[HIV protease inhibitors for the treatment of Kaposi's sarcoma] 249
Inflammatory cytokines increase mesenchymal cell growth and attachment induced by HIV-1 Tat protein and adhesion molecules: implications for AIDS-Kaposi’s sarcoma pathogenesis. 237
Activated peripheral blood lymphocytes produce factors promoting the growth of spindle cells derived from AIDS-associated Kaposi’s sarcoma. 210
Correlation between pathological data and the RNA expression of p53 or p53-targeted genes in primary invasive ductal breast carcinomas: a preliminary study 63
Proteasome inhibition by bortezomib parallels a reduction in head and neck cancer cells growth, and an increase in tumor-infiltrating immune cells 61
Combined treatment with inhibitors of ErbB Receptors and Hh signaling pathways is more effective than single treatment in reducing the growth of malignant mesothelioma both in vitro and in vivo 58
The Anti-angiogenic effects of anti-human immunodeficiency virus drugs 56
HIV-1 tat protein enters dysfunctional endothelial cells via integrins and renders them permissive to virus replication 49
Antitumoral effects of Bortezomib in malignant mesothelioma: evidence of mild endoplasmic reticulum stress in vitro and activation of T cell response in vivo 47
The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo 45
The impact of human papilloma viruses, matrix metallo-proteinases and HIV protease inhibitors on the onset and progression of uterine cervix epithelial tumors: A review of preclinical and clinical studies 44
Radioresistance in rhabdomyosarcomas: much more than a question of dose 43
The Combination of Immune Checkpoint Blockade with Tumor Vessel Normalization as a Promising Therapeutic Strategy for Breast Cancer: An Overview of Preclinical and Clinical Studies 36
Dietary Polyphenols Effects on Focal Adhesion Plaques and Metalloproteinases in Cancer Invasiveness 34
The Impact of matrix metalloproteinase-9 on the sequential steps of the metastatic process 33
Spermine oxidase induces DNA damage and sensitizes fusion negative rhabdomyosarcoma cells to irradiation 32
Totale 29.381
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.382
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.382
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.486 0 0 0 0 0 913 662 620 618 704 509 460
2020/20214.351 485 462 553 554 461 569 520 339 108 73 200 27
2021/2022919 19 130 13 63 18 43 48 119 32 54 85 295
2022/20231.326 159 110 100 143 97 276 113 80 123 43 68 14
2023/2024458 49 13 23 17 38 159 20 12 10 38 17 62
2024/20251.358 91 675 324 136 52 80 0 0 0 0 0 0
Totale 29.699